A detailed history of Mercer Global Advisors Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 583,664 shares of GILD stock, worth $54.8 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
583,664
Previous 231,698 151.91%
Holding current value
$54.8 Million
Previous $15.9 Million 207.76%
% of portfolio
0.11%
Previous 0.04%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$66.59 - $83.99 $23.4 Million - $29.6 Million
351,966 Added 151.91%
583,664 $48.9 Million
Q2 2024

Aug 12, 2024

SELL
$63.15 - $72.88 $7.84 Million - $9.04 Million
-124,073 Reduced 34.87%
231,698 $15.9 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $2.25 Million - $2.75 Million
31,485 Added 9.71%
355,771 $26.1 Million
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $919,831 - $1.04 Million
12,554 Added 4.03%
324,286 $26.3 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $3.25 Million - $3.55 Million
44,015 Added 16.44%
311,732 $23.4 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $2.37 Million - $2.71 Million
31,208 Added 13.2%
267,717 $20.6 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $2.85 Million - $3.24 Million
36,818 Added 18.44%
236,509 $19.6 Million
Q4 2022

Feb 08, 2023

BUY
$62.32 - $89.47 $6.56 Million - $9.41 Million
105,214 Added 111.36%
199,691 $17.1 Million
Q3 2022

Nov 15, 2022

BUY
$59.54 - $68.01 $763,779 - $872,432
12,828 Added 15.71%
94,477 $5.83 Million
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $78,383 - $88,283
-1,358 Reduced 1.64%
81,649 $5.05 Million
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $610,650 - $765,210
10,543 Added 14.55%
83,007 $4.94 Million
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $468,174 - $531,386
7,216 Added 11.06%
72,464 $5.26 Million
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $234,951 - $253,487
3,471 Added 5.62%
65,248 $4.56 Million
Q2 2021

Aug 10, 2021

BUY
$63.47 - $69.35 $100,599 - $109,919
1,585 Added 2.63%
61,777 $4.25 Million
Q1 2021

Aug 10, 2021

BUY
$60.0 - $68.46 $186,960 - $213,321
3,116 Added 5.46%
60,192 $3.89 Million
Q1 2021

May 11, 2021

BUY
$60.0 - $68.46 $957,240 - $1.09 Million
15,954 Added 38.8%
57,076 $3.69 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $579,812 - $660,669
-10,235 Reduced 19.93%
41,122 $2.4 Million
Q3 2020

Dec 10, 2020

BUY
$62.1 - $78.08 $26,703 - $33,574
430 Added 0.84%
51,357 $3.25 Million
Q2 2020

Aug 10, 2020

SELL
$72.34 - $84.0 $352,006 - $408,744
-4,866 Reduced 8.72%
50,927 $3.92 Million
Q1 2020

May 18, 2020

SELL
$62.63 - $80.22 $2.24 Million - $2.87 Million
-35,738 Reduced 39.04%
55,793 $4.17 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $299,288 - $329,207
4,857 Added 5.6%
91,531 $5.95 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $2.72 Million - $3.01 Million
43,564 Added 101.05%
86,674 $5.49 Million
Q2 2019

Aug 14, 2019

BUY
$61.87 - $69.38 $7,300 - $8,186
118 Added 0.27%
43,110 $2.91 Million
Q1 2019

Apr 23, 2019

BUY
$62.53 - $70.05 $383,871 - $430,036
6,139 Added 16.66%
42,992 $2.8 Million
Q1 2019

Apr 12, 2019

BUY
$62.53 - $70.05 $2.3 Million - $2.58 Million
36,853 New
36,853 $2.31 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.